Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2024 Earnings Call Transcript August 11, 2024
Operator: Good afternoon, and welcome to the Eaton Pharmaceuticals Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please be advised, this call is being recorded at the company’s request. At this time, I’d like to turn it over to David Krempa, Chief Business Officer at Eaton Pharmaceuticals. Please proceed.
David Krempa: Good afternoon, everyone, and welcome to Eton’s...
